{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T21:54:17Z","timestamp":1783634057801,"version":"3.55.0"},"reference-count":103,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2003,12,1]],"date-time":"2003-12-01T00:00:00Z","timestamp":1070236800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biochemical Pharmacology"],"published-print":{"date-parts":[[2003,12]]},"DOI":"10.1016\/j.bcp.2003.07.007","type":"journal-article","created":{"date-parts":[[2003,10,11]],"date-time":"2003-10-11T05:52:40Z","timestamp":1065851560000},"page":"2075-2088","source":"Crossref","is-referenced-by-count":100,"title":["Effects of dietary flavonoids on major signal transduction pathways in human epithelial cells"],"prefix":"10.1016","volume":"66","author":[{"given":"Jim","family":"O\u2019Prey","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judith","family":"Brown","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janis","family":"Fleming","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul R","family":"Harrison","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bcp.2003.07.007_BIB1","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1080\/01635589409514342","article-title":"Dietary flavonoids and cancer risk in the Zutphen Elderly Study","volume":"22","author":"Hertog","year":"1994","journal-title":"Nutr. Cancer"},{"issue":"4","key":"10.1016\/j.bcp.2003.07.007_BIB2","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1001\/archinte.1995.00430040053006","article-title":"Flavonoid intake and long-term risk of coronary heart disease and cancer in the seven countries study","volume":"155","author":"Hertog","year":"1995","journal-title":"Arch. Intern. Med."},{"issue":"1","key":"10.1016\/j.bcp.2003.07.007_BIB3","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1080\/01635589309514267","article-title":"Intake of potentially anticarcinogenic flavonoids and their determinants in adults in The Netherlands","volume":"20","author":"Hertog","year":"1993","journal-title":"Nutr. Cancer"},{"key":"10.1016\/j.bcp.2003.07.007_BIB4","doi-asserted-by":"crossref","first-page":"2379","DOI":"10.1021\/jf00024a011","article-title":"Content of potentially anticarcinogenic flavenoids of 28 vegetables and 9 fruits commonly consumed in The Netherlands","volume":"40","author":"Hertog","year":"1992","journal-title":"J. Agric. Food Chem."},{"issue":"3","key":"10.1016\/j.bcp.2003.07.007_BIB5","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1093\/oxfordjournals.aje.a009257","article-title":"Dietary flavonoids and the risk of lung cancer and other malignant neoplasms","volume":"146","author":"Knekt","year":"1997","journal-title":"Am. J. Epidemiol."},{"issue":"2","key":"10.1016\/j.bcp.2003.07.007_BIB6","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1093\/jnci\/92.2.154","article-title":"Intake of flavonoids and lung cancer","volume":"92","author":"Le Marchand","year":"2000","journal-title":"J. Natl. Cancer Inst."},{"issue":"2","key":"10.1016\/j.bcp.2003.07.007_BIB7","first-page":"63","article-title":"Potential health effects of the dietary flavonol quercetin","volume":"50","author":"Hertog","year":"1996","journal-title":"Eur. J. Clin. Nutr."},{"issue":"8","key":"10.1016\/j.bcp.2003.07.007_BIB8","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/S0753-3322(97)88045-6","article-title":"Absorption, metabolism and health effects of dietary flavonoids in man","volume":"51","author":"Hollman","year":"1997","journal-title":"Biomed. Pharmacother."},{"issue":"4","key":"10.1016\/j.bcp.2003.07.007_BIB9","doi-asserted-by":"crossref","first-page":"198","DOI":"10.3181\/00379727-220-44365","article-title":"Tea flavonols in cardiovascular disease and cancer epidemiology","volume":"220","author":"Hollman","year":"1999","journal-title":"Proc. Soc. Exp. Biol. Med."},{"issue":"6","key":"10.1016\/j.bcp.2003.07.007_BIB10","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1097\/00075197-200011000-00006","article-title":"Plant-derived phenolic antioxidants","volume":"3","author":"Duthie","year":"2000","journal-title":"Curr. Opin. Clin. Nutr. Metab. Care"},{"issue":"9\/10","key":"10.1016\/j.bcp.2003.07.007_BIB11","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1016\/S0278-6915(99)00079-4","article-title":"Dietary flavonoids: intake, health effects and bioavailability","volume":"37","author":"Hollman","year":"1999","journal-title":"Food Chem. Toxicol."},{"issue":"7","key":"10.1016\/j.bcp.2003.07.007_BIB12","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1093\/carcin\/12.7.1193","article-title":"Quercetin and rutin as inhibitors of azoxymethanol-induced colonic neoplasia","volume":"12","author":"Deschner","year":"1991","journal-title":"Carcinogenesis"},{"issue":"6","key":"10.1016\/j.bcp.2003.07.007_BIB13","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1093\/carcin\/17.6.1305","article-title":"Effects of the phytochemicals, curcumin and quercetin, upon azoxymethane-induced colon cancer and 7,12-dimethylbenz[a]anthracene-induced mammary cancer in rats","volume":"17","author":"Pereira","year":"1996","journal-title":"Carcinogenesis"},{"issue":"20","key":"10.1016\/j.bcp.2003.07.007_BIB14","first-page":"5754","article-title":"Inhibition of 7,12-dimethylbenz(a)anthracene- and N-nitrosomethylurea-induced rat mammary cancer by dietary flavonol quercetin","volume":"48","author":"Verma","year":"1988","journal-title":"Cancer Res."},{"issue":"4","key":"10.1016\/j.bcp.2003.07.007_BIB15","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1093\/carcin\/17.4.877","article-title":"Inhibitory effect of dietary flavonol quercetin on 7,12-dimethylbenz[a]anthracene-induced hamster buccal pouch carcinogenesis","volume":"17","author":"Balasubramanian","year":"1996","journal-title":"Carcinogenesis"},{"issue":"10","key":"10.1016\/j.bcp.2003.07.007_BIB16","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1093\/carcin\/10.10.1929","article-title":"Possible involvement of arachidonic acid metabolism in phenobarbital promotion of hepatocarcinogenesis","volume":"10","author":"Denda","year":"1989","journal-title":"Carcinogenesis"},{"issue":"3","key":"10.1016\/j.bcp.2003.07.007_BIB17","first-page":"499","article-title":"Inhibitory effect of apigenin, curcumin and quercetin, upon azoxymethane-induced colon cancer and 7,12-dimethylbenz[a]anthracene-induced mammary cancer in rats","volume":"50","author":"Wei","year":"1990","journal-title":"Cancer Res."},{"issue":"10","key":"10.1016\/j.bcp.2003.07.007_BIB18","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1093\/carcin\/4.10.1301","article-title":"Inhibition of 12-O-tetradecanoylphorbol-13-acetate-induced tumour promotion and ornithine decarboxylase activity by quercetin: possible involvement of lipoxygenase inhibition","volume":"4","author":"Kato","year":"1983","journal-title":"Carcinogenesis"},{"issue":"2","key":"10.1016\/j.bcp.2003.07.007_BIB19","first-page":"246","article-title":"Chemoprevention of 4-nitroquinoline 1-oxide-induced oral carcinogenesis in rats by flavonoids diosmin and hesperidin, each alone and in combination","volume":"57","author":"Tanaka","year":"1997","journal-title":"Cancer Res."},{"key":"10.1016\/j.bcp.2003.07.007_BIB20","unstructured":"Fujiki H, Horiuchi T, Yamashita K, Hakii H, Suganuma M, Nishino H, Iwashima A, Hirata Y, Sugimura T. In: A.R. Liss, editor. Plant FVs in biology and medicine: biochemical, pharmacological and structure\u2013activity relationships; 1986. p. 429\u201340."},{"issue":"1A","key":"10.1016\/j.bcp.2003.07.007_BIB21","first-page":"85","article-title":"Inhibition of ultraviolet light induced skin carcinogenesis in SKH-1 mice by apigenin, a plant flavonoid","volume":"17","author":"Birt","year":"1997","journal-title":"Anticancer Res."},{"issue":"3","key":"10.1016\/j.bcp.2003.07.007_BIB22","first-page":"622","article-title":"A flavonoid antioxidant, silymarin, affords exceptionally high protection against tumour promotion in the SENCAR mouse skin tumourigenesis model","volume":"59","author":"Lahiri-Chatterjee","year":"1999","journal-title":"Cancer Res."},{"issue":"2\/3","key":"10.1016\/j.bcp.2003.07.007_BIB23","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S0163-7258(01)00137-1","article-title":"Dietary agents in cancer prevention: flavonoids and isoflavonoids","volume":"90","author":"Birt","year":"2001","journal-title":"Pharmacol. Ther."},{"issue":"9","key":"10.1016\/j.bcp.2003.07.007_BIB24","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1517\/13543784.9.9.2103","article-title":"The therapeutic potential of flavonoids","volume":"9","author":"Wang","year":"2000","journal-title":"Expert Opin. Investig. Drugs"},{"issue":"9","key":"10.1016\/j.bcp.2003.07.007_BIB25","doi-asserted-by":"crossref","first-page":"2986","DOI":"10.1200\/JCO.1998.16.9.2986","article-title":"Phase I trial of continuous infusion flavopiridol, a novel cyclin-dependent kinase inhibitor, in patients with refractory neoplasms","volume":"16","author":"Senderowicz","year":"1998","journal-title":"J. Clin. Oncol."},{"issue":"7","key":"10.1016\/j.bcp.2003.07.007_BIB26","doi-asserted-by":"crossref","first-page":"1985","DOI":"10.1200\/JCO.2001.19.7.1985","article-title":"Phase II study of the cyclin-dependent kinase inhibitor flavopiridol administered to patients with advanced gastric carcinoma","volume":"19","author":"Schwartz","year":"2001","journal-title":"J. Clin. Oncol."},{"issue":"12","key":"10.1016\/j.bcp.2003.07.007_BIB27","doi-asserted-by":"crossref","first-page":"2903","DOI":"10.1517\/13543784.9.12.2903","article-title":"Flavopiridol, the first cyclin-dependent kinase inhibitor to enter the clinic: current status","volume":"9","author":"Kelland","year":"2000","journal-title":"Expert Opin. Investig Drugs"},{"issue":"7","key":"10.1016\/j.bcp.2003.07.007_BIB28","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1016\/0891-5849(95)02227-9","article-title":"Structure-antioxidant activity relationships of flavonoids and phenolic acids","volume":"20","author":"Rice-Evans","year":"1996","journal-title":"Free Radic Biol. Med."},{"issue":"15","key":"10.1016\/j.bcp.2003.07.007_BIB29","doi-asserted-by":"crossref","first-page":"2987","DOI":"10.1016\/0006-2952(88)90286-9","article-title":"Differential effects of flavonoids as inhibitors of tyrosine protein kinases and serine\/threonine protein kinases","volume":"37","author":"Hagiwara","year":"1988","journal-title":"Biochem. Pharmacol."},{"issue":"10","key":"10.1016\/j.bcp.2003.07.007_BIB30","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1016\/0006-2952(89)90309-2","article-title":"Protein kinase C inhibition by plant flavonoids. Kinetic mechanisms and structure\u2013activity relationships","volume":"38","author":"Ferriola","year":"1989","journal-title":"Biochem. Pharmacol."},{"issue":"11","key":"10.1016\/j.bcp.2003.07.007_BIB31","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1016\/S0006-2952(97)82453-7","article-title":"Relationship between flavonoid structure and inhibition of phosphatidylinositol 3-kinase: a comparison with tyrosine kinase and protein kinase C inhibition","volume":"53","author":"Agullo","year":"1997","journal-title":"Biochem. Pharmacol."},{"issue":"1","key":"10.1016\/j.bcp.2003.07.007_BIB32","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/0959-8049(95)00540-4","article-title":"Inhibitions of protein kinase C and proto-oncogene expressions in NIH 3T3 cells by apigenin","volume":"32A","author":"Huang","year":"1996","journal-title":"Eur. J. Cancer"},{"issue":"1","key":"10.1016\/j.bcp.2003.07.007_BIB33","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1006\/bbrc.1995.1355","article-title":"Quercetin down-regulates signal transduction in human breast carcinoma cells","volume":"208","author":"Singhal","year":"1995","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"7","key":"10.1016\/j.bcp.2003.07.007_BIB34","doi-asserted-by":"crossref","first-page":"2735","DOI":"10.1073\/pnas.93.7.2735","article-title":"Structural basis for specificity and potency of a flavonoid inhibitor of human CDK2, a cell cycle kinase","volume":"93","author":"De Azevedo","year":"1996","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"issue":"2","key":"10.1016\/j.bcp.2003.07.007_BIB35","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1006\/bbrc.1994.1742","article-title":"Potent inhibition of CDC2 kinase activity by the flavonoid L86-8275","volume":"201","author":"Losiewicz","year":"1994","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"9","key":"10.1016\/j.bcp.2003.07.007_BIB36","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1016\/0006-2952(91)90501-U","article-title":"Inhibition of mammalian 5-lipoxygenase and cyclo-oxygenase by flavonoids and phenolic dietary additives. Relationship to antioxidant activity and to iron ion-reducing ability","volume":"42","author":"Laughton","year":"1991","journal-title":"Biochem. Pharmacol."},{"issue":"1","key":"10.1016\/j.bcp.2003.07.007_BIB37","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1093\/carcin\/7.1.33","article-title":"In vitro inhibition of mouse epidermal cell lipoxygenase by flavonoids: structure\u2013activity relationships","volume":"7","author":"Wheeler","year":"1986","journal-title":"Carcinogenesis"},{"issue":"1","key":"10.1016\/j.bcp.2003.07.007_BIB38","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S0952-3278(98)90125-9","article-title":"Effects of naturally-occurring flavonoids and biflavonoids on epidermal cyclooxygenase and lipoxygenase from guinea-pigs","volume":"58","author":"Kim","year":"1998","journal-title":"Prostaglandins Leukot Essent Fatty Acids"},{"issue":"4","key":"10.1016\/j.bcp.2003.07.007_BIB39","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/0090-6980(80)90103-3","article-title":"Flavonoids and related compounds as inhibition of arachidonic acid peroxidation","volume":"20","author":"Baumann","year":"1980","journal-title":"Prostaglandins"},{"issue":"2","key":"10.1016\/j.bcp.2003.07.007_BIB40","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1006\/bbrc.1998.8748","article-title":"Skin cancer chemopreventive effects of a flavonoid antioxidant silymarin are mediated via impairment of receptor tyrosine kinase signalling and perturbation in cell cycle progression","volume":"247","author":"Ahmad","year":"1998","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"1","key":"10.1016\/j.bcp.2003.07.007_BIB41","first-page":"351","article-title":"Flavonoids with epidermal growth factor-receptor tyrosine kinase inhibitory activity stimulate PEPT1-mediated cefixime uptake into human intestinal epithelial cells","volume":"299","author":"Wenzel","year":"2001","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"3","key":"10.1016\/j.bcp.2003.07.007_BIB42","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1006\/bbrc.1995.2035","article-title":"Reversion of v-H-ras-transformed NIH 3T3 cells by apigenin through inhibiting mitogen-activated protein kinase and its downstream oncogenes","volume":"212","author":"Kuo","year":"1995","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"2","key":"10.1016\/j.bcp.2003.07.007_BIB43","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1002\/(SICI)1098-2744(199707)19:2<74::AID-MC2>3.0.CO;2-L","article-title":"Induction of p21\/WAF1 and G1 cell-cycle arrest by the chemopreventive agent apigenin","volume":"19","author":"Lepley","year":"1997","journal-title":"Mol. Carcinogen."},{"issue":"11","key":"10.1016\/j.bcp.2003.07.007_BIB44","doi-asserted-by":"crossref","first-page":"2367","DOI":"10.1093\/carcin\/17.11.2367","article-title":"The chemopreventive flavonoid apigenin induces G2\/M arrest in keratinocytes","volume":"17","author":"Lepley","year":"1996","journal-title":"Carcinogenesis"},{"issue":"9","key":"10.1016\/j.bcp.2003.07.007_BIB45","first-page":"1920","article-title":"A flavonoid antioxidant, silymarin, inhibits activation of erbB1 signalling and induces cyclin-dependent kinase inhibitors, G1 arrest, and anticarcinogenic effects in human prostate carcinoma DU145 cells","volume":"58","author":"Zi","year":"1998","journal-title":"Cancer Res."},{"issue":"13","key":"10.1016\/j.bcp.2003.07.007_BIB46","first-page":"2973","article-title":"Flavopiridol induces G1 arrest with inhibition of cyclin-dependent kinase (CDK)2 and CDK4 in human breast carcinoma cells","volume":"56","author":"Carlson","year":"1996","journal-title":"Cancer Res."},{"issue":"10","key":"10.1016\/j.bcp.2003.07.007_BIB47","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1016\/S0006-2952(01)00583-4","article-title":"Effects of structurally related flavonoids on cell cycle progression of human melanoma cells: regulation of cyclin-dependent kinases CDK2 and CDK1","volume":"61","author":"Casagrande","year":"2001","journal-title":"Biochem. Pharmacol."},{"issue":"1","key":"10.1016\/j.bcp.2003.07.007_BIB48","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1002\/mc.10016","article-title":"A p21(waf1)-independent pathway for inhibitory phosphorylation of cyclin-dependent kinase p34(cdc2) and concomitant G(2)\/M arrest by the chemopreventive flavonoid apigenin","volume":"33","author":"McVean","year":"2002","journal-title":"Mol. Carcinogen."},{"issue":"2","key":"10.1016\/j.bcp.2003.07.007_BIB49","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1002\/1098-2744(200006)28:2<102::AID-MC6>3.0.CO;2-2","article-title":"Cell-cycle arrest at G2\/M and growth inhibition by apigenin in human colon carcinoma cell lines","volume":"28","author":"Wang","year":"2000","journal-title":"Mol. Carcinogen."},{"issue":"8","key":"10.1016\/j.bcp.2003.07.007_BIB50","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1016\/S0006-2952(00)00385-3","article-title":"Cell signalling and regulators of cell cycle as molecular targets for prostate cancer prevention by dietary agents","volume":"60","author":"Agarwal","year":"2000","journal-title":"Biochem. Pharmacol."},{"issue":"3\/4","key":"10.1016\/j.bcp.2003.07.007_BIB51","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/0960-0760(94)90030-2","article-title":"Lignans and flavonoids inhibit aromatase enzyme in human preadipocytes","volume":"50","author":"Wang","year":"1994","journal-title":"J. Steroid Biochem. Mol. Biol."},{"issue":"3","key":"10.1016\/j.bcp.2003.07.007_BIB52","doi-asserted-by":"crossref","first-page":"310","DOI":"10.3181\/00379727-217-44237","article-title":"Inhibition of 17beta-hydroxysteroid oxidoreductase by flavonoids in breast and prostate cancer cells","volume":"217","author":"Makela","year":"1998","journal-title":"Proc. Soc. Exp. Biol. Med."},{"issue":"14","key":"10.1016\/j.bcp.2003.07.007_BIB53","first-page":"2916","article-title":"Flavonoids, dietary-derived inhibitors of cell proliferation and in vitro angiogenesis","volume":"57","author":"Fotsis","year":"1997","journal-title":"Cancer Res."},{"issue":"5","key":"10.1016\/j.bcp.2003.07.007_BIB54","first-page":"1657","article-title":"Tumourigenic keratinocyte lines requiring anchorage and fibroblast support cultures from human squamous cell carcinomas","volume":"41","author":"Rheinwald","year":"1981","journal-title":"Cancer Res."},{"issue":"18","key":"10.1016\/j.bcp.2003.07.007_BIB55","first-page":"3886","article-title":"Inappropriate retinoic acid receptor-beta expression in oral dysplasias: correlation with acquisition of the immortal phenotype","volume":"57","author":"McGregor","year":"1997","journal-title":"Cancer Res."},{"key":"10.1016\/j.bcp.2003.07.007_BIB56","unstructured":"McGregor F, Muntoni A, Fleming J, Brown J, Felix DH, MacDonald G, Parkinspon EK, Harrison PR. Molecular changes associated with oral dysplasia progression and acquisition of immortality: potential for its reversal by 5-azacytidine, Cancer Res 2002;62."},{"issue":"4","key":"10.1016\/j.bcp.2003.07.007_BIB57","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1002\/mc.2940130408","article-title":"Cellular immortality: a late event in the progression of human squamous cell carcinoma of the head and neck associated with p53 alteration and a high frequency of allele loss","volume":"13","author":"Edington","year":"1995","journal-title":"Mol. Carcinogen."},{"issue":"2","key":"10.1016\/j.bcp.2003.07.007_BIB58","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/S0006-291X(88)80271-7","article-title":"Molecular cloning and primary structure of human 15-lipoxygenase","volume":"157","author":"Sigal","year":"1988","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"1","key":"10.1016\/j.bcp.2003.07.007_BIB59","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1073\/pnas.85.1.26","article-title":"Molecular cloning and amino acid sequence of human 5-lipoxygenase","volume":"85","author":"Matsumoto","year":"1988","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"issue":"19","key":"10.1016\/j.bcp.2003.07.007_BIB60","doi-asserted-by":"crossref","first-page":"7477","DOI":"10.1073\/pnas.87.19.7477","article-title":"Cloning of the cDNA for human 12-lipoxygenase","volume":"87","author":"Izumi","year":"1990","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"issue":"12","key":"10.1016\/j.bcp.2003.07.007_BIB61","doi-asserted-by":"crossref","first-page":"6148","DOI":"10.1073\/pnas.94.12.6148","article-title":"Discovery of a second 15S-lipoxygenase in humans","volume":"94","author":"Brash","year":"1997","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"issue":"28","key":"10.1016\/j.bcp.2003.07.007_BIB62","doi-asserted-by":"crossref","first-page":"16586","DOI":"10.1074\/jbc.271.28.16586","article-title":"Big mitogen-activated protein kinase 1 (BMK1) is a redox-sensitive kinase","volume":"271","author":"Abe","year":"1996","journal-title":"J. Biol. Chem."},{"issue":"5383","key":"10.1016\/j.bcp.2003.07.007_BIB63","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1126\/science.281.5383.1677","article-title":"Activation of the ATM kinase by ionizing radiation and phosphorylation of p53","volume":"281","author":"Canman","year":"1998","journal-title":"Science"},{"key":"10.1016\/j.bcp.2003.07.007_BIB64","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/S0962-8924(97)01105-7","article-title":"The search for physiological substrates of MAP and SAP kinases in mammalian cells","volume":"7","author":"Cohen","year":"1997","journal-title":"Trends Cell Biol."},{"issue":"6703","key":"10.1016\/j.bcp.2003.07.007_BIB65","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1038\/27234","article-title":"Bmk1\/Erk5 is required for cell proliferation induced by epidermal growth factor","volume":"395","author":"Kato","year":"1998","journal-title":"Nature"},{"issue":"49","key":"10.1016\/j.bcp.2003.07.007_BIB66","doi-asserted-by":"crossref","first-page":"31234","DOI":"10.1016\/S0021-9258(18)47414-5","article-title":"Activation of the mitogen-activated protein kinase signalling pathway in neutrophils. Role of oxidants","volume":"269","author":"Fialkow","year":"1994","journal-title":"J. Biol. Chem."},{"issue":"8","key":"10.1016\/j.bcp.2003.07.007_BIB67","doi-asserted-by":"crossref","first-page":"4138","DOI":"10.1074\/jbc.271.8.4138","article-title":"Activation of mitogen-activated protein kinase by H2O2. Role in cell survival following oxidant injury","volume":"271","author":"Guyton","year":"1996","journal-title":"J. Biol. Chem."},{"issue":"4","key":"10.1016\/j.bcp.2003.07.007_BIB68","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/S0092-8674(00)81883-8","article-title":"PI3K: downstream AKTion blocks apoptosis","volume":"88","author":"Franke","year":"1997","journal-title":"Cell"},{"issue":"10","key":"10.1016\/j.bcp.2003.07.007_BIB69","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/S0962-8924(01)02119-5","article-title":"Integrating stress\u2013response and cell-cycle checkpoint pathways","volume":"11","author":"Pearce","year":"2001","journal-title":"Trends Cell Biol."},{"issue":"15","key":"10.1016\/j.bcp.2003.07.007_BIB70","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1038\/sj.onc.1204252","article-title":"Regulation of the G2\/M transition by p53","volume":"20","author":"Taylor","year":"2001","journal-title":"Oncogene"},{"issue":"Pt 1","key":"10.1016\/j.bcp.2003.07.007_BIB71","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1042\/bj3510095","article-title":"Specificity and mechanism of action of some commonly used protein kinase inhibitors","volume":"351","author":"Davies","year":"2000","journal-title":"Biochem. J."},{"issue":"20","key":"10.1016\/j.bcp.2003.07.007_BIB72","first-page":"7479","article-title":"Enhanced sensitivity of human oral carcinomas to induction of apoptosis by selenium compounds: involvement of mitogen-activated protein kinase and Fas pathways","volume":"61","author":"Ghose","year":"2001","journal-title":"Cancer Res."},{"issue":"45","key":"10.1016\/j.bcp.2003.07.007_BIB73","doi-asserted-by":"crossref","first-page":"6135","DOI":"10.1038\/sj.onc.1203124","article-title":"ATM: a mediator of multiple responses to genotoxic stress","volume":"18","author":"Rotman","year":"1999","journal-title":"Oncogene"},{"issue":"6","key":"10.1016\/j.bcp.2003.07.007_BIB74","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/S0955-0674(00)00154-X","article-title":"Cell-cycle checkpoint kinases: checking in on the cell cycle","volume":"12","author":"Walworth","year":"2000","journal-title":"Curr. Opin. Cell Biol."},{"issue":"19","key":"10.1016\/j.bcp.2003.07.007_BIB75","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1016\/S0960-9822(99)80486-2","article-title":"Caffeine inhibits the checkpoint kinase ATM","volume":"9","author":"Blasina","year":"1999","journal-title":"Curr. Biol."},{"issue":"17","key":"10.1016\/j.bcp.2003.07.007_BIB76","first-page":"4375","article-title":"Inhibition of ATM and ATR kinase activities by the radiosensitizing agent, caffeine","volume":"59","author":"Sarkaria","year":"1999","journal-title":"Cancer Res."},{"issue":"14","key":"10.1016\/j.bcp.2003.07.007_BIB77","doi-asserted-by":"crossref","first-page":"10342","DOI":"10.1074\/jbc.275.14.10342","article-title":"Caffeine abolishes the mammalian G(2)\/M DNA damage checkpoint by inhibiting ataxia-telangiectasia-mutated kinase activity","volume":"275","author":"Zhou","year":"2000","journal-title":"J. Biol. Chem."},{"issue":"22","key":"10.1016\/j.bcp.2003.07.007_BIB78","first-page":"7139","article-title":"Effects of fatty acids and inhibitors of eicosanoid synthesis on the growth of a human breast cancer cell line in culture","volume":"50","author":"Rose","year":"1990","journal-title":"Cancer Res."},{"issue":"32","key":"10.1016\/j.bcp.2003.07.007_BIB79","doi-asserted-by":"crossref","first-page":"24500","DOI":"10.1074\/jbc.M003145200","article-title":"Increased AKT activity contributes to prostate cancer progression by dramatically accelerating prostate tumour growth and diminishing p27Kip1 expression","volume":"275","author":"Graff","year":"2000","journal-title":"J. Biol. Chem."},{"issue":"3","key":"10.1016\/j.bcp.2003.07.007_BIB80","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/S0306-3623(98)00220-1","article-title":"Flavonoids and the inhibition of PKC and PI-3-kinase","volume":"32","author":"Gamet-Payrastre","year":"1999","journal-title":"Gen. Pharmacol."},{"issue":"4","key":"10.1016\/j.bcp.2003.07.007_BIB81","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1038\/bjc.1994.356","article-title":"The p53 status of cultured human premalignant oral keratinocytes","volume":"70","author":"Burns","year":"1994","journal-title":"Br J. Cancer"},{"issue":"11","key":"10.1016\/j.bcp.2003.07.007_BIB82","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1038\/sj.onc.1203444","article-title":"Ionizing radiation activates the ATM kinase throughout the cell cycle","volume":"19","author":"Pandita","year":"2000","journal-title":"Oncogene"},{"issue":"27","key":"10.1016\/j.bcp.2003.07.007_BIB83","doi-asserted-by":"crossref","first-page":"3989","DOI":"10.1038\/sj.onc.1202973","article-title":"The ataxia-telangiectasia related protein ATR mediates DNA-dependent phosphorylation of p53","volume":"18","author":"Lakin","year":"1999","journal-title":"Oncogene"},{"issue":"4","key":"10.1016\/j.bcp.2003.07.007_BIB84","doi-asserted-by":"crossref","first-page":"R121","DOI":"10.1016\/S0960-9822(01)00057-4","article-title":"Replication checkpoint: preventing mitotic catastrophe","volume":"11","author":"Canman","year":"2001","journal-title":"Curr. Biol."},{"issue":"Pt 22","key":"10.1016\/j.bcp.2003.07.007_BIB85","doi-asserted-by":"crossref","first-page":"3889","DOI":"10.1242\/jcs.113.22.3889","article-title":"Chk1 and Cds1: linchpins of the DNA damage and replication checkpoint pathways","volume":"113","author":"Rhind","year":"2000","journal-title":"J. Cell Sci."},{"issue":"1","key":"10.1016\/j.bcp.2003.07.007_BIB86","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1093\/emboj\/17.1.159","article-title":"Overexpression of a kinase-inactive ATR protein causes sensitivity to DNA-damaging agents and defects in cell cycle checkpoints","volume":"17","author":"Cliby","year":"1998","journal-title":"EMBO. J."},{"issue":"19","key":"10.1016\/j.bcp.2003.07.007_BIB87","doi-asserted-by":"crossref","first-page":"10389","DOI":"10.1073\/pnas.190030497","article-title":"Ataxia-telangiectasia-mutated phosphorylates Chk2 in vivo and in vitro","volume":"97","author":"Matsuoka","year":"2000","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"issue":"13","key":"10.1016\/j.bcp.2003.07.007_BIB88","doi-asserted-by":"crossref","first-page":"4129","DOI":"10.1128\/MCB.21.13.4129-4139.2001","article-title":"ATR-mediated checkpoint pathways regulate phosphorylation and activation of human Chk1","volume":"21","author":"Zhao","year":"2001","journal-title":"Mol. Cell Biol."},{"issue":"12","key":"10.1016\/j.bcp.2003.07.007_BIB89","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1101\/gad.14.12.1448","article-title":"Chk1 is an essential kinase that is regulated by Atr and required for the G(2)\/M DNA damage checkpoint","volume":"14","author":"Liu","year":"2000","journal-title":"Genes Dev."},{"issue":"13","key":"10.1016\/j.bcp.2003.07.007_BIB90","doi-asserted-by":"crossref","first-page":"4543","DOI":"10.1128\/MCB.20.13.4543-4552.2000","article-title":"Involvement of the MKK6-p38gamma cascade in gamma-radiation-induced cell cycle arrest","volume":"20","author":"Wang","year":"2000","journal-title":"Mol. Cell Biol."},{"issue":"6833","key":"10.1016\/j.bcp.2003.07.007_BIB91","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1038\/35075107","article-title":"Initiation of a G2\/M checkpoint after ultraviolet radiation requires p38 kinase","volume":"411","author":"Bulavin","year":"2001","journal-title":"Nature"},{"issue":"7","key":"10.1016\/j.bcp.2003.07.007_BIB92","doi-asserted-by":"crossref","first-page":"4828","DOI":"10.1074\/jbc.M004894200","article-title":"The plant isoflavenoid genistein activates p53 and Chk2 in an ATM-dependent manner","volume":"276","author":"Ye","year":"2001","journal-title":"J. Biol. Chem."},{"issue":"20","key":"10.1016\/j.bcp.2003.07.007_BIB93","doi-asserted-by":"crossref","first-page":"15363","DOI":"10.1074\/jbc.275.20.15363","article-title":"Distinct Chk2 activation pathways are triggered by genistein and DNA-damaging agents in human melanoma cells","volume":"275","author":"Darbon","year":"2000","journal-title":"J. Biol. Chem."},{"issue":"6","key":"10.1016\/j.bcp.2003.07.007_BIB94","first-page":"1782","article-title":"Differential sensitivity of normal and malignant breast epithelial cells to genistein is partly mediated by p21(WAF1)","volume":"7","author":"Upadhyay","year":"2001","journal-title":"Clin. Cancer Res."},{"issue":"1","key":"10.1016\/j.bcp.2003.07.007_BIB95","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1093\/ajcn\/68.1.60","article-title":"Plasma concentrations and urinary excretion of the antioxidant flavonols quercetin and kaempferol as biomarkers for dietary intake","volume":"68","author":"de Vries","year":"1998","journal-title":"Am. J. Clin. Nutr."},{"key":"10.1016\/j.bcp.2003.07.007_BIB96","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1007\/978-3-642-46856-8_21","article-title":"Bioavailability and health effects of dietary flavonols in man","volume":"20","author":"Hollman","year":"1998","journal-title":"Arch. Toxicol. Suppl."},{"issue":"3","key":"10.1016\/j.bcp.2003.07.007_BIB97","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1093\/jn\/131.3.745","article-title":"Red wine is a poor source of bioavailable flavonols in men","volume":"131","author":"de Vries","year":"2001","journal-title":"J. Nutr."},{"key":"10.1016\/j.bcp.2003.07.007_BIB98","unstructured":"Scheline RR. CRC handbook of mammalian metabolism of plant compounds. Boston: CRC Press; 1991."},{"issue":"1\/2","key":"10.1016\/j.bcp.2003.07.007_BIB99","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/S0014-5793(97)01367-7","article-title":"Relative bioavailability of the antioxidant flavonoid quercetin from various foods in man","volume":"418","author":"Hollman","year":"1997","journal-title":"FEBS Lett."},{"issue":"2","key":"10.1016\/j.bcp.2003.07.007_BIB100","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1038\/sj.ejcn.1600908","article-title":"Prediction of dietary flavonol consumption from fasting plasma concentration or urinary excretion","volume":"54","author":"Noroozi","year":"2000","journal-title":"Eur. J. Clin. Nutr."},{"issue":"5","key":"10.1016\/j.bcp.2003.07.007_BIB101","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1093\/jn\/130.5.1200","article-title":"Bioavailabilities of quercetin-3-glucoside and quercetin-4\u2032-glucoside do not differ in humans","volume":"130","author":"Olthof","year":"2000","journal-title":"J. Nutr."},{"issue":"1","key":"10.1016\/j.bcp.2003.07.007_BIB102","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1038\/sj.bjp.0704064","article-title":"Antihypertensive effects of the flavonoid quercetin in spontaneously hypertensive rats","volume":"133","author":"Duarte","year":"2001","journal-title":"Br. J. Pharmacol."},{"issue":"2","key":"10.1016\/j.bcp.2003.07.007_BIB103","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1093\/carcin\/24.2.171","article-title":"Enhanced sensitivity of human oral tumours to the flavonol, morin, during cancer progression: involvement of the Akt and stress kinase pathways","volume":"24","author":"Brown","year":"2003","journal-title":"Carcinogenesis"}],"container-title":["Biochemical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295203005938?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295203005938?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,4,27]],"date-time":"2023-04-27T03:36:56Z","timestamp":1682566616000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006295203005938"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,12]]},"references-count":103,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2003,12]]}},"alternative-id":["S0006295203005938"],"URL":"https:\/\/doi.org\/10.1016\/j.bcp.2003.07.007","relation":{},"ISSN":["0006-2952"],"issn-type":[{"value":"0006-2952","type":"print"}],"subject":[],"published":{"date-parts":[[2003,12]]}}}